| __timestamp | Teva Pharmaceutical Industries Limited | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9216000000 | 5903000 |
| Thursday, January 1, 2015 | 8296000000 | 2762000 |
| Friday, January 1, 2016 | 10044000000 | 1114000 |
| Sunday, January 1, 2017 | 11560000000 | 25573000 |
| Monday, January 1, 2018 | 10558000000 | 6000000 |
| Tuesday, January 1, 2019 | 9351000000 | 38845000 |
| Wednesday, January 1, 2020 | 8933000000 | 50523000 |
| Friday, January 1, 2021 | 8284000000 | 75463000 |
| Saturday, January 1, 2022 | 7952000000 | 105767000 |
| Sunday, January 1, 2023 | 8200000000 | 167512000 |
| Monday, January 1, 2024 | 8480000000 |
In pursuit of knowledge
In the ever-evolving landscape of pharmaceuticals, understanding cost structures is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Xenon Pharmaceuticals Inc. have showcased contrasting trajectories in their cost of revenue. Teva, a giant in the industry, saw its cost of revenue peak in 2017, reaching approximately 11.56 billion USD, before experiencing a gradual decline to around 8.2 billion USD by 2023. This represents a reduction of nearly 30% over six years, reflecting strategic cost management and market adjustments.
Conversely, Xenon Pharmaceuticals, a smaller player, has witnessed a remarkable increase in its cost of revenue, from a modest 5.9 million USD in 2014 to a substantial 167.5 million USD in 2023. This growth, over 2800%, underscores Xenon's aggressive expansion and investment in research and development. As the pharmaceutical sector continues to innovate, these cost trends offer valuable insights into the strategic priorities of these companies.
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Exelixis, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Perrigo Company plc vs Xenon Pharmaceuticals Inc.
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for Xenon Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Xenon Pharmaceuticals Inc. vs Celldex Therapeutics, Inc.